semaglutide fda news The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of data showed. Added FDA alerts health care providers,

Between 40% and 60% of survey respondents reported being much better or better able to meet target blood sugars upon fasting, waking or after eating

Its unsettling to notice, but its typically short-lived and reversible

Will I experience side effects again

The star had a drastic transformation soon after, telling host Kelly Clarkson, "I'm doing that wonderful shot that works for folks who need some help and it's been really good for me." She revealed her weight loss had been so successful that she'd lost the body weight of two people

There were dose-dependent outcomes across patient subgroups

Thus, semaglutide 2.4 mg is safe and well tolerated at a minimum of 1 year after MBS